These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22815222)

  • 61. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM; Fawzy N; Fawzi MM; Karam RA
    J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.
    Gratacòs M; González JR; Mercader JM; de Cid R; Urretavizcaya M; Estivill X
    Biol Psychiatry; 2007 Apr; 61(7):911-22. PubMed ID: 17217930
    [TBL] [Abstract][Full Text] [Related]  

  • 63. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
    Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
    Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users.
    Roviš D; Černelič Bizjak M; Vasiljev Marchesi V; Petelin A; Jenuš T; Vidic S; Drevenšek G; Jenko Pražnikar Z
    Eur Addict Res; 2018; 24(4):189-200. PubMed ID: 30134233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons.
    Chen ZY; Patel PD; Sant G; Meng CX; Teng KK; Hempstead BL; Lee FS
    J Neurosci; 2004 May; 24(18):4401-11. PubMed ID: 15128854
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of the BDNF Val66Met Polymorphism on Gray Matter Volume in Typically Developing Children and Adolescents.
    Hashimoto T; Fukui K; Takeuchi H; Yokota S; Kikuchi Y; Tomita H; Taki Y; Kawashima R
    Cereb Cortex; 2016 Apr; 26(4):1795-803. PubMed ID: 26830347
    [TBL] [Abstract][Full Text] [Related]  

  • 67. BDNF polymorphism-dependent OFC and DLPFC plasticity differentially moderates implicit and explicit bias.
    Forbes CE; Poore JC; Barbey AK; Krueger F; Solomon J; Lipsky RH; Hodgkinson CA; Goldman D; Grafman J
    Cereb Cortex; 2012 Nov; 22(11):2602-9. PubMed ID: 22123938
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder.
    Moreira FP; Fabião JD; Bittencourt G; Wiener CD; Jansen K; Oses JP; Quevedo Lde Á; Souza LD; Crispim D; Portela LV; Pinheiro RT; Lara DR; Kaster MP; da Silva RA; Ghisleni G
    Psychiatr Genet; 2015 Oct; 25(5):201-7. PubMed ID: 26110341
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interaction of Brain-Derived Neurotrophic Factor Val66Met genotype and history of stress in regulation of prepulse inhibition in mice.
    van den Buuse M; Lee JJW; Jaehne EJ
    Schizophr Res; 2018 Aug; 198():60-67. PubMed ID: 28864281
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response.
    Flanagin BA; Cook EH; de Wit H
    Am J Med Genet B Neuropsychiatr Genet; 2006 Sep; 141B(6):576-83. PubMed ID: 16823800
    [TBL] [Abstract][Full Text] [Related]  

  • 71. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects.
    Jiang X; Xu K; Hoberman J; Tian F; Marko AJ; Waheed JF; Harris CR; Marini AM; Enoch MA; Lipsky RH
    Neuropsychopharmacology; 2005 Jul; 30(7):1353-61. PubMed ID: 15770238
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Severe publication bias contributes to illusory sleep consolidation in the motor sequence learning literature.
    Rickard TC; Pan SC; Gupta MW
    J Exp Psychol Learn Mem Cogn; 2022 Dec; 48(12):1787-1796. PubMed ID: 35084925
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect Sizes, Power, and Biases in Intelligence Research: A Meta-Meta-Analysis.
    Nuijten MB; van Assen MALM; Augusteijn HEM; Crompvoets EAV; Wicherts JM
    J Intell; 2020 Oct; 8(4):. PubMed ID: 33023250
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The albatross plot: A novel graphical tool for presenting results of diversely reported studies in a systematic review.
    Harrison S; Jones HE; Martin RM; Lewis SJ; Higgins JPT
    Res Synth Methods; 2017 Sep; 8(3):281-289. PubMed ID: 28453179
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Telomeres as integrative markers of exposure to stress and adversity: a systematic review and meta-analysis.
    Pepper GV; Bateson M; Nettle D
    R Soc Open Sci; 2018 Aug; 5(8):180744. PubMed ID: 30225068
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of systematic effects of methodological characteristics on candidate genetic associations.
    Aljasir B; Ioannidis JP; Yurkiewich A; Moher D; Higgins JP; Arora P; Little J
    Hum Genet; 2013 Feb; 132(2):167-78. PubMed ID: 23095857
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of health on economic growth: a meta-regression analysis.
    Ridhwan MM; Nijkamp P; Ismail A; M Irsyad L
    Empir Econ; 2022; 63(6):3211-3251. PubMed ID: 35431414
    [TBL] [Abstract][Full Text] [Related]  

  • 78. emagnification: A tool for estimating effect-size magnification and performing design calculations in epidemiological studies.
    Miller DJ; Nguyen JT; Bottai M
    Stata J; 2020; 20(3):548-564. PubMed ID: 34434078
    [TBL] [Abstract][Full Text] [Related]  

  • 79. BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.
    Harrisberger F; Smieskova R; Schmidt A; Lenz C; Walter A; Wittfeld K; Grabe HJ; Lang UE; Fusar-Poli P; Borgwardt S
    Neurosci Biobehav Rev; 2015 Aug; 55():107-18. PubMed ID: 25956254
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interaction of Val66Met BDNF and 5-HTTLPR polymorphisms with prevalence of post-earthquake 27-F PTSD in Chilean population.
    Castillo-Navarrete JL; Vicente B; Schmidt K; Moraga-Escobar E; Rojas-Ponce R; Lagos P; Macaya X; Guzman-Castillo A
    PeerJ; 2023; 11():e15870. PubMed ID: 37692110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.